BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zaheed O, Samson J, Dean K. A bioinformatics approach to identify novel long, non-coding RNAs in breast cancer cell lines from an existing RNA-sequencing dataset. Noncoding RNA Res 2020;5:48-59. [PMID: 32206740 DOI: 10.1016/j.ncrna.2020.02.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Afzal O, Akhter MH, Ahmad I, Muzammil K, Dawria A, Zeyaullah M, Altamimi ASA, Khalilullah H, Mir Najib Ullah SN, Rahman MA, Ali A, Shahzad N, Jaremko M, Emwas A, Abdel Aziz Ibrahim I. A β–Sitosterol Encapsulated Biocompatible Alginate/Chitosan Polymer Nanocomposite for the Treatment of Breast Cancer. Pharmaceutics 2022;14:1711. [DOI: 10.3390/pharmaceutics14081711] [Reference Citation Analysis]
2 Gupta R, Kala N, Pai A, Malviya R. Bioinformatics Approach for Data Capturing: The Case of Breast Cancer. CCTR 2021;17:261-6. [DOI: 10.2174/1573394717666210203112941] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Qin AC, Qian Y, Ma YY, Jiang Y, Qian WF. Long Non-coding RNA RP11-395G23.3 Acts as a Competing Endogenous RNA of miR-124-3p to Regulate ROR1 in Anaplastic Thyroid Carcinoma. Front Genet 2021;12:673242. [PMID: 34421987 DOI: 10.3389/fgene.2021.673242] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Samson J, Derlipanska M, Zaheed O, Dean K. Molecular and cellular characterization of two patient-derived ductal carcinoma in situ (DCIS) cell lines, ETCC-006 and ETCC-010. BMC Cancer 2021;21:790. [PMID: 34238275 DOI: 10.1186/s12885-021-08511-2] [Reference Citation Analysis]
5 Rajarajan D, Kaur B, Penta D, Natesh J, Meeran SM. miR-145-5p as a predictive biomarker for breast cancer stemness by computational clinical investigation. Comput Biol Med 2021;135:104601. [PMID: 34186326 DOI: 10.1016/j.compbiomed.2021.104601] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Liu Y, Tu H, Zhang L, Xiong J, Li L. FOXP3‑induced LINC00885 promotes the proliferation and invasion of cervical cancer cells. Mol Med Rep 2021;23:458. [PMID: 33880574 DOI: 10.3892/mmr.2021.12097] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Yin D, Lu X. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells. Bioengineered 2021;12:225-39. [PMID: 33371778 DOI: 10.1080/21655979.2020.1863619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bahreyni A, Mohamud Y, Luo H. Emerging nanomedicines for effective breast cancer immunotherapy. J Nanobiotechnology 2020;18:180. [PMID: 33298099 DOI: 10.1186/s12951-020-00741-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
9 Abba MC, Canzoneri R, Gurruchaga A, Lee J, Tatineni P, Kil H, Lacunza E, Aldaz CM. LINC00885 a Novel Oncogenic Long Non-Coding RNA Associated with Early Stage Breast Cancer Progression. Int J Mol Sci 2020;21:E7407. [PMID: 33049922 DOI: 10.3390/ijms21197407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
10 Sher G, Salman NA, Khan AQ, Prabhu KS, Raza A, Kulinski M, Dermime S, Haris M, Junejo K, Uddin S. Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications. Semin Cancer Biol 2020:S1044-579X(20)30181-4. [PMID: 32858230 DOI: 10.1016/j.semcancer.2020.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]